Candriam SCA’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-338,000
| Closed | -$1.73M | – | 810 |
|
|
2019
Q3 | $1.73M | Sell |
338,000
-40,000
| -11% | -$205K | 0.02% | 522 |
|
|
2019
Q2 | $2.7M | Sell |
378,000
-600,000
| -61% | -$4.28M | 0.03% | 448 |
|
|
2019
Q1 | $13M | Hold |
978,000
| – | – | 0.17% | 142 |
|
|
2018
Q4 | $7.7M | Buy |
978,000
+20,000
| +2% | +$157K | 0.12% | 200 |
|
|
2018
Q3 | $10.6M | Buy |
958,000
+488,000
| +104% | +$5.41M | 0.14% | 180 |
|
|
2018
Q2 | $6.31M | Buy |
470,000
+225,000
| +92% | +$3.02M | 0.1% | 255 |
|
|
2018
Q1 | $3.18M | Buy |
245,000
+110,000
| +81% | +$1.43M | 0.05% | 374 |
|
|
2017
Q4 | $1.24M | Buy |
+135,000
| New | +$1.24M | 0.02% | 552 |
|